
|Videos|August 26, 2021
Part 1: Practical Considerations For Venetoclax in AML
Alexandra S. Wolff, PharmD, BCOP, highlights considerations for optimal use of venetoclax in patients with AML, such as tumor lysis syndrome prophylaxis.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Reimagining Pharmacy: A Call to Action for Pharmacy Professionals
2
FDA Approves Milestone Oral Therapy for Adults With Thalassemia Anemia
3
Lowering Blood Glucose in Prediabetes May Prevent Heart Attacks and Heart Failure
4
Experimental Multistage Malaria Vaccine Demonstrates Promising Protection in Early Trial
5










































































































































































































